Libra Follow-Up: How Much Of The Life Engine Actually Reaches Shareholders
Libra’s life engine is scaling fast, but the number that matters to shareholders is not gross CSM. By the end of 2025 gross CSM stood at NIS 30.9 million, while the retained balance after held reinsurance stood at only NIS 15.0 million.
Why This Follow-up Exists
The main article argued that Libra is already looking more like a real earnings insurer, but that the life story still needed to be separated from the broader group read. This follow-up isolates that point. It does not ask whether life is growing. That is already visible. It asks how much of that growth actually remains at Libra, after reinsurance, and how investors should read the CSM, the contractual service margin, as future profit that has not yet reached shareholders.
That matters because the easiest number to latch onto is gross CSM. In the presentation it looks dramatic. But at Libra gross is only the start of the story. The company operates its life book with a 70% Quota Share reinsurance treaty, so a large part of the future economics of the portfolio is ceded to reinsurers from day one.
Four numbers hold the entire thesis:
- Gross life premiums rose to NIS 13.0 million in 2025 from NIS 6.1 million in 2024, while annualized premium rose to NIS 18.1 million from NIS 7.7 million.
- Year-end gross CSM reached NIS 30.9 million, up from NIS 8.7 million a year earlier.
- But year-end retained CSM stood at only NIS 15.0 million, versus NIS 2.9 million at the end of 2024.
- Out of NIS 4.1 million of gross CSM release for services provided in 2025, only NIS 1.9 million remained in Libra’s net profit bridge after held reinsurance contracts.
Gross Really Did Jump, but Gross Is Not the Shareholder Answer
The pace of book building is hard to dispute. Gross life premiums rose by about 113% in 2025 to NIS 13.0 million, and annualized premium rose to NIS 18.1 million. That gap matters. It shows that the run-rate with which the life book exited 2025 was already above the premium base that flowed through the full-year numbers, so the engine is genuinely building fast.
The gross CSM line also looks strong. By the end of 2025 Libra stood at NIS 30.9 million of gross CSM, versus NIS 8.7 million at the end of 2024. The presentation frames the path even more sharply: from NIS 4 million at the start of 2024 to NIS 9 million at year-end 2024 and NIS 31 million at year-end 2025. The visible message is clear: the future-profit reservoir in life is no longer trivial.
But that is still not enough for the common shareholder. The same directors’ report that highlights gross CSM also states explicitly that retained CSM rose to NIS 15.0 million, not NIS 30.9 million. In other words, only about half of the gross year-end reservoir remained with Libra, while the other half sat on the side of held reinsurance contracts.
| Core life metric | 2024 | 2025 | What really matters |
|---|---|---|---|
| Gross premiums | NIS 6.1 million | NIS 13.0 million | The sales pace accelerated sharply |
| Annualized premium | NIS 7.7 million | NIS 18.1 million | The exit rate already runs above the full-year premium base |
| Year-end gross CSM | NIS 8.7 million | NIS 30.9 million | The gross future-profit reservoir expanded materially |
| Held reinsurance CSM | NIS 5.8 million | NIS 15.9 million | A large share of future economics sits with reinsurers |
| Year-end retained CSM | NIS 2.9 million | NIS 15.0 million | This is the figure closer to shareholder economics |
| Net CSM release to profit | NIS 0.5 million | NIS 1.9 million | Conversion into current earnings remains modest relative to the reservoir |
That chart is the core of the story. It does not say the life engine is weak. Quite the opposite. It says the engine is real, but investors should not confuse the size of the engine with the part Libra actually keeps.
The 70% Reinsurance Layer Is Not a Footnote
Libra’s main life reinsurance treaty is a 70% Quota Share arrangement. The 2025 split is explicit: Swiss Re at 35%, Hannover at 20%, and Arch Re at 15%. In the same section the company explains that under this treaty it cedes the relative share of premium and claims to reinsurers, while also receiving commission out of premiums and a profit commission.
That is exactly why gross and retained do not move together. On one side, the treaty pushes a meaningful part of the future book outside Libra. On the other, the structure includes commissions and Profit Commission, so the economics that remain at the company are not just a mechanical 30% slice of gross. That helps explain why year-end retained CSM stood at about 48.6% of gross CSM, not merely one third.
The cleanest way to see the point is through the 2025 new business cohort. Contracts recognized for the first time during the year generated NIS 17.173 million of gross CSM. At the same time, held reinsurance contracts generated NIS 9.971 million of CSM. So the new business written in 2025 left Libra with about NIS 7.2 million of net CSM, before ongoing release and assumption changes.
That number matters more than the headline gross-growth slide. If an investor reads only the NIS 17.2 million of new gross CSM, it is easy to think the life engine has already built a large future-profit pipeline for shareholders. In practice, after reinsurers, the portion of CSM retained from 2025 new business was about 41.9% of gross. That is higher than the retained share implied by the end-2024 balance, but it is also a much more accurate read of what actually stayed inside the company.
Even When the Profit Starts Releasing, Only Part of It Reaches Libra’s P&L
The same principle operates at the next stage, when CSM starts to flow into earnings. In 2025 Libra recognized NIS 4.092 million of gross CSM release for services provided. At the same time, the held reinsurance side recognized NIS 2.229 million of CSM release. That is why the life-segment profit bridge shows only NIS 1.863 million of CSM release actually contributing to profit.
This is also why the current P&L line is still much smaller than the future-profit reservoir. The life segment ended 2025 with NIS 3.964 million of total pre-tax profit, including NIS 1.931 million of insurance service profit and NIS 2.033 million of investment and finance income, net. So the life engine is already producing profit, but most of the value still sits ahead, not in the 2025 income line.
The future release schedule makes the same point. Out of NIS 30.9 million of gross CSM, the company shows NIS 6.0 million expected to reach profit within one year. But on the held reinsurance side, NIS 3.0 million is scheduled to release over the same horizon. So the portion that stays with Libra over the next year is only about NIS 2.9 million.
That last chart sharpens the real argument. Gross CSM says there is a future engine. Retained CSM says how much of that engine still sits inside Libra’s economics. And the release schedule shows that the issue is not only size, but also timing. Only about NIS 2.9 million currently sits in the up-to-one-year retained bucket, with the rest spread over much longer horizons.
What This Means for Shareholders
Libra’s life engine is more real than it looked a year ago. That is visible in premiums, annualized premium, gross CSM, and retained CSM alike. But the right number to read the shareholder thesis from is not NIS 30.9 million of gross CSM. The better number is NIS 15.0 million of retained CSM, of which only NIS 2.9 million is scheduled to run through profit within a year based on the end-2025 balance.
That does not mean the life engine is weak. It means the engine still has a double-layer structure. One layer is the gross engine, which is growing very fast. The second layer is the economics that remain with Libra after held reinsurance. As long as investors read only the gross number, it is easy to overstate how much of that growth already belongs to shareholders.
So the right late-2025 headline is not that Libra has already built a full second life engine. It is that the company has built a strong gross life engine that currently translates into a smaller but growing retained engine. If annualized premium keeps rising and retained CSM continues to grow faster than the amount already being released through earnings, this can absolutely become a material second engine over time. By the end of 2025 it is no longer negligible, but it is also not yet reaching shareholders at the scale that gross CSM alone implies.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.